OneSource Specialty Pharma Strengthens its Board with Key Independent Directors Appointment
The directors bring decades of leadership experience and expertise in Pharma, Business Strategy, Transformation, Merger & Acquisition (M&A) among others.
OneSource Specialty Pharma | 12/03/2025 | By Aishwarya
OneSource Achieves INR 3,926 Million Revenue in Q3FY25
OneSource demonstrated exceptional profitability with EBITDA reaching INR 1,432 million, an 85 percent increase compared to the previous quarter, resulting in a robust EBITDA margin of 36.5 percent, up by 1,334 basis points quarter-on-quarter.
OneSource Specialty Pharma | 01/02/2025 | By Aishwarya | 169
OneSource Unveils New Brand Identity at CPHI Milan
OneSource’s end-to-end offering across all its platforms was established in response to its customers’ need to streamline supply chains by consolidating their outsourcing partners.
OneSource Specialty Pharma | 08/10/2024 | By Aishwarya | 210
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy